T1	Disorder 2252 2262	asbestosis
T7	Disorder 2420 2429	silicosis
T9	GGPs 564 569	MMP-9
T11	Subject 1528 1536	patients
T12	Disorder 1621 1634	lung fibrosis
T16	Anatomical_entity 1409 1414	serum
T17	Anatomical_entity 1148 1153	serum
T21	GGPs 545 550	MMP-2
T22	Disorder 1215 1225	asbestosis
T23	Disorder 1471 1481	asbestosis
T25	Disorder 633 642	silicosis
T26	Subject 616 627	45 patients
T27	GGPs 553 558	MMP-7
T30	Disorder 406 414	diseases
T31	GGPs 2141 2151	biomarkers
T32	GGPs 2344 2349	MMP-2
T35	Subject 1234 1242	patients
T36	Subject 1999 2007	patients
T37	GGPs 929 938	biomarker
T38	Subject 587 598	43 patients
T40	Disorder 205 215	Asbestosis
T41	Disorder 2405 2415	asbestosis
T42	GGPs 1980 1984	SP-D
T43	Disorder 1350 1359	silicosis
T47	GGPs 517 543	matrix metalloproteinase-2
T49	Disorder 604 614	asbestosis
T51	Disorder 1248 1257	silicosis
T52	Disorder 2013 2023	asbestosis
T53	Disorder 2529 2538	silicosis
T58	GGPs 2334 2338	SP-D
T59	GGPs 1990 1995	MMP-2
T60	Disorder 1497 1506	silicosis
T61	Anatomical_entity 999 1004	serum
T62	Disorder 2514 2524	asbestosis
T63	Subject 1483 1491	patients
T65	Disorder 220 229	silicosis
T68	Disorder 2267 2276	silicosis
T69	GGPs 1810 1814	SP-D
T70	Disorder 144 154	asbestosis
T72	Subject 1457 1465	patients
T73	Subject 1201 1209	patients
T74	Disorder 2101 2110	silicosis
T79	Anatomical_entity 429 434	serum
T81	GGPs 1014 1019	MMP-2
T82	Disorder 683 697	pneumoconiosis
T83	Subject 1336 1344	patients
T84	Disorder 1542 1552	asbestosis
T88	Disorder 278 299	interstitial fibrosis
T89	GGPs 1154 1158	SP-D
T92	GGPs 74 101	matrix  metalloproteinase-2
T95	Anatomical_entity 730 735	Chest
T97	GGPs 48 68	surfactant protein D
T99	GGPs 2460 2470	biomarkers
T105	Anatomical_entity 1804 1809	serum
T106	Inorganic_compound 334 345	silica dust
T107	Anatomical_entity 0 5	Serum
T111	Subject 1051 1059	patients
T113	GGPs 506 510	SP-D
T114	GGPs 1819 1824	MMP-2
T116	Disorder 1065 1075	asbestosis
T118	Anatomical_entity 1558 1563	serum
T119	GGPs 484 504	surfactant protein D
T120	Entity_Property 234 245	progressive
T124	Disorder 2075 2085	asbestosis
T125	Subject 130 138	patients
T126	Disorder 159 168	silicosis
T129	Subject 2061 2069	patients
T131	Disorder 2195 2205	asbestosis
T133	GGPs 2364 2374	biomarkers
T134	GGPs 1415 1420	MMP-7
T135	Subject 644 646;660 667	40 workers
N1	Reference T1 UMLS:C0003949	Asbestosis
N17	Reference T7 UMLS:C0037116	Silicosis
N23	Reference T9 UMLS:C0165519	Matrix Metalloproteinase 9
N26	Reference T11 UMLS:C0030705	Patients
N28	Reference T12 UMLS:C0034069	Pulmonary Fibrosis
N49	Reference T16 UMLS:C0229671	Serum
N54	Reference T17 UMLS:C0229671	Serum
N71	Reference T21 UMLS:C0172537	Matrix Metalloproteinase 2
N73	Reference T22 UMLS:C0003949	Asbestosis
N75	Reference T23 UMLS:C0003949	Asbestosis
N79	Reference T25 UMLS:C0037116	Silicosis
N81	Reference T26 UMLS:C0030705	Patients
N86	Reference T27 UMLS:C0166059	Matrix Metalloproteinase 7
N105	Reference T30 UMLS:C0012634	Disease
N108	Reference T31 UMLS:C0005516	Biological Markers
N110	Reference T32 UMLS:C0172537	Matrix Metalloproteinase 2
N121	Reference T35 UMLS:C0030705	Patients
N123	Reference T36 UMLS:C0030705	Patients
N126	Reference T37 UMLS:C0005516	Biological Markers
N127	Reference T38 UMLS:C0030705	Patients
N131	Reference T40 UMLS:C0003949	Asbestosis
N133	Reference T41 UMLS:C0003949	Asbestosis
N141	Reference T42 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N142	Reference T43 UMLS:C0037116	Silicosis
N158	Reference T47 UMLS:C0172537	Matrix Metalloproteinase 2
N162	Reference T49 UMLS:C0003949	Asbestosis
N166	Reference T51 UMLS:C0037116	Silicosis
N168	Reference T52 UMLS:C0003949	Asbestosis
N170	Reference T53 UMLS:C0037116	Silicosis
N193	Reference T58 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N195	Reference T59 UMLS:C0172537	Matrix Metalloproteinase 2
N197	Reference T60 UMLS:C0037116	Silicosis
N203	Reference T61 UMLS:C0229671	Serum
N204	Reference T62 UMLS:C0003949	Asbestosis
N206	Reference T63 UMLS:C0030705	Patients
N210	Reference T65 UMLS:C0037116	Silicosis
N216	Reference T68 UMLS:C0037116	Silicosis
N224	Reference T69 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N225	Reference T70 UMLS:C0003949	Asbestosis
N233	Reference T72 UMLS:C0030705	Patients
N235	Reference T73 UMLS:C0030705	Patients
N237	Reference T74 UMLS:C0037116	Silicosis
N264	Reference T79 UMLS:C0229671	Serum
N272	Reference T81 UMLS:C0172537	Matrix Metalloproteinase 2
N276	Reference T82 UMLS:C0032273	Pneumoconiosis
N277	Reference T83 UMLS:C0030705	Patients
N279	Reference T84 UMLS:C0003949	Asbestosis
N296	Reference T88 UMLS:C3887486	Interstitial lung fibrosis
N306	Reference T89 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N312	Reference T92 UMLS:C0172537	Matrix Metalloproteinase 2
N319	Reference T95 UMLS:C0817096	Chest
N329	Reference T97 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N338	Reference T99 UMLS:C0005516	Biological Markers
N360	Reference T105 UMLS:C0229671	Serum
N361	Reference T106 UMLS:C0729394	Silica dust
N367	Reference T107 UMLS:C0229671	Serum
N380	Reference T111 UMLS:C0030705	Patients
N393	Reference T113 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N395	Reference T114 UMLS:C0172537	Matrix Metalloproteinase 2
N399	Reference T116 UMLS:C0003949	Asbestosis
N407	Reference T118 UMLS:C0229671	Serum
N414	Reference T119 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N416	Reference T120 UMLS:C0205329	Progressive
N429	Reference T124 UMLS:C0003949	Asbestosis
N431	Reference T125 UMLS:C0030705	Patients
N433	Reference T126 UMLS:C0037116	Silicosis
N439	Reference T129 UMLS:C0030705	Patients
N450	Reference T131 UMLS:C0003949	Asbestosis
N455	Reference T133 UMLS:C0005516	Biological Markers
N459	Reference T134 UMLS:C0166059	Matrix Metalloproteinase 7
T137	Method_cue 736 771	high-resolution computed tomography
N2	Reference T137 UMLS:C1512457	High Resolution Computed Tomography
T13	Disorder 246 260	pneumoconioses
N4	Reference T13 UMLS:C0032273	Pneumoconiosis
T44	GGPs 24 46	Krebs von den Lungen-6
N10	Reference T44 UMLS:C0057628	Mucin-1 protein
T71	GGPs 453 475	Krebs von den Lungen-6
N12	Reference T71 UMLS:C0057628	Mucin-1 protein
T4	GGPs 477 481	KL-6
N7	Reference T4 UMLS:C0057628	Mucin-1 protein
T117	GGPs 1005 1009	KL-6
N13	Reference T117 UMLS:C0057628	Mucin-1 protein
T138	GGPs 1564 1568	KL-6
N14	Reference T138 UMLS:C0057628	Mucin-1 protein
T139	GGPs 1974 1978	KL-6
N18	Reference T139 UMLS:C0057628	Mucin-1 protein
T140	GGPs 2328 2332	KL-6
N20	Reference T140 UMLS:C0057628	Mucin-1 protein
T112	GGPs 1415 1418;1424 1426	MMP -9
N21	Reference T112 UMLS:C0165519	Matrix Metalloproteinase 9
T18	Subject 703 722	45 healthy controls
N25	Reference T18 UMLS:C2986479	Healthy Control
T67	Subject 724 727	HCs
N27	Reference T67 UMLS:C2986479	Healthy Control
T77	Subject 1127 1130	HCs
N29	Reference T77 UMLS:C2986479	Healthy Control
T101	Subject 1269 1272	HCs
N30	Reference T101 UMLS:C2986479	Healthy Control
T109	Subject 1371 1374	HCs
N31	Reference T109 UMLS:C2986479	Healthy Control
T141	Subject 1517 1520	HCs
N32	Reference T141 UMLS:C2986479	Healthy Control
T91	Subject 130 138	patients
N33	Reference T91 UMLS:C0030705	Patients
N34	Reference T135 UMLS:C1306056	Worker
T143	Inorganic_compound 322 330	asbestos
N35	Reference T143 UMLS:C0003947	Asbestos
R1	Subject_Disorder Arg1:T91 Arg2:T70	
R2	Subject_Disorder Arg1:T125 Arg2:T126	
R3	Subject_Disorder Arg1:T38 Arg2:T49	
R4	Subject_Disorder Arg1:T26 Arg2:T25	
R5	Subject_Disorder Arg1:T111 Arg2:T116	
R6	Subject_Disorder Arg1:T73 Arg2:T22	
R7	Subject_Disorder Arg1:T35 Arg2:T51	
R8	Subject_Disorder Arg1:T83 Arg2:T43	
R9	Subject_Disorder Arg1:T72 Arg2:T23	
R10	Subject_Disorder Arg1:T63 Arg2:T60	
R11	Subject_Disorder Arg1:T11 Arg2:T84	
R12	Subject_Disorder Arg1:T36 Arg2:T52	
R13	Subject_Disorder Arg1:T129 Arg2:T124	
T98	Subject 669 673	DEWs
N42	Reference T98 UMLS:C1306056	Worker
T123	Subject 1118 1122	DEWs
N44	Reference T123 UMLS:C1306056	Worker
T146	Subject 1259 1263	DEWs
N45	Reference T146 UMLS:C1306056	Worker
T147	Subject 1361 1365	DEWs
N46	Reference T147 UMLS:C1306056	Worker
T148	Subject 1508 1512	DEWs
N47	Reference T148 UMLS:C1306056	Worker
T24	Measurement 1685 1724	forced vital capacity (FVC) % predicted
N40	Reference T24 UMLS:C2919678	Percentage of predicted forced vital capacity
T54	Measurement 1729 1798	diffusing capacity of the lung for carbon monoxide (DLCO) % predicted
N48	Reference T54 UMLS:C4054207	Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide
T50	Measurement 1876 1892	DLCO % predicted
N22	Reference T50 UMLS:C4054207	Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide
T121	Method_cue 773 777	HRCT
N56	Reference T121 UMLS:C1512457	High Resolution Computed Tomography
T127	Correlation 1856 1866	correlated
E7	Correlation:T127 Theme:T114 Theme2:T50
N57	Reference E7 UMLS:C0332281	Associated with
E9	Correlation:T127 Theme:T69 Theme2:T50
N58	Reference E9 UMLS:C0332281	Associated with
T19	Correlation 261 274	characterized
E2	Correlation:T19 Theme:T65 Theme2:T88
N51	Reference E2 UMLS:C0332281	Associated with
E4	Correlation:T19 Theme:T40 Theme2:T88
N52	Reference E4 UMLS:C0332281	Associated with
T80	Correlation 1601 1611	correlated
E6	Correlation:T80 Theme:T138 Theme2:T12 Cue:T33
N53	Reference E6 UMLS:C0332281	Associated with
T85	Correlation 1665 1675	correlated
E10	Correlation:T85 Theme:T138 Theme2:T24 Theme3:T54
N59	Reference E10 UMLS:C0332281	Associated with
T33	Method_cue 1645 1649	HRCT
N63	Reference T33 UMLS:C1512457	High Resolution Computed Tomography
T100	Artificial_process 2392 2401	diagnosis
E8	Artificial_process:T100 Theme:T41
N50	Reference E8 UMLS:C0011900	Diagnosis
E11	Artificial_process:T100 Theme:T7
N62	Reference E11 UMLS:C0011900	Diagnosis
T6	Disorder 234 260	progressive pneumoconioses
N11	Reference T6 UMLS:C0032273	Pneumoconiosis
R20	member_of Arg1:T6 Arg2:T13	
R21	member_of Arg1:T140 Arg2:T133	
R22	member_of Arg1:T58 Arg2:T133	
R23	member_of Arg1:T32 Arg2:T133	
A1	Speculated E6
